Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Breath of Health is a private medical diagnostics company developing non-invasive breath-analysis tools for early disease detection. Its platform combines spectroscopy, molecular breath analysis, cloud software, and artificial intelligence to identify disease-associated biomarkers in exhaled breath. Publicly available descriptions indicate applications in cancer screening, COVID-19 detection, neurodegenerative disease detection, and broader pulmonary and infectious disease screening. The company appears to operate as a diagnostics and health-technology business rather than a therapeutics developer, so it does not have a conventional drug pipeline. Breath of Health has been described as active, for-profit, and founded in 2020, with operations connected to Israel and the United States.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Breath Health.